Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | thymidine phosphorylase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | Get druggable targets OG5_131632 | All targets in OG5_131632 |
Echinococcus granulosus | thymidine phosphorylase | Get druggable targets OG5_131632 | All targets in OG5_131632 |
Mycobacterium ulcerans | thymidine phosphorylase | Get druggable targets OG5_131632 | All targets in OG5_131632 |
Echinococcus multilocularis | thymidine phosphorylase | Get druggable targets OG5_131632 | All targets in OG5_131632 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | tyrosine kinase | 0.0162 | 0.1021 | 0.32 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0132 | 0.0581 | 0.0581 |
Echinococcus multilocularis | thymidine phosphorylase | 0.0765 | 1 | 1 |
Mycobacterium tuberculosis | Probable thymidine phosphorylase DeoA (tdrpase) (pyrimidine phosphorylase) | 0.0765 | 1 | 1 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0162 | 0.1021 | 0.1021 |
Echinococcus multilocularis | mitogen activated protein kinase 11 | 0.0132 | 0.0581 | 0.0581 |
Schistosoma mansoni | tyrosine kinase | 0.016 | 0.0996 | 0.3117 |
Loa Loa (eye worm) | CMGC/MAPK/P38 protein kinase | 0.0132 | 0.0581 | 0.1757 |
Leishmania major | mitogen-activated protein kinase 3, putative,map kinase 3, putative | 0.0132 | 0.0581 | 0.5 |
Brugia malayi | P38 map kinase family protein 2 | 0.0132 | 0.0581 | 0.1757 |
Schistosoma mansoni | tyrosine kinase | 0.0301 | 0.3095 | 1 |
Loa Loa (eye worm) | TK/EGFR protein kinase | 0.0301 | 0.3095 | 1 |
Schistosoma mansoni | tyrosine kinase | 0.016 | 0.0996 | 0.3117 |
Schistosoma mansoni | tyrosine kinase | 0.016 | 0.0996 | 0.3117 |
Echinococcus multilocularis | insulin growth factor 1 receptor beta | 0.0096 | 0.0045 | 0.0045 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0301 | 0.3095 | 0.3064 |
Echinococcus granulosus | mitogen activated protein kinase 14 | 0.0132 | 0.0581 | 0.0538 |
Mycobacterium leprae | Probable anthranilate phosphoribosyltransferase TrpD | 0.0216 | 0.1827 | 0.5 |
Echinococcus granulosus | melanoma receptor tyrosine protein kinase | 0.0162 | 0.1021 | 0.098 |
Mycobacterium ulcerans | thymidine phosphorylase | 0.0765 | 1 | 1 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0132 | 0.0581 | 0.0581 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0132 | 0.0581 | 0.5 |
Schistosoma mansoni | tyrosine kinase | 0.0162 | 0.1021 | 0.32 |
Echinococcus multilocularis | insulin receptor | 0.0096 | 0.0045 | 0.0045 |
Echinococcus multilocularis | mitogen activated protein kinase 14 | 0.0132 | 0.0581 | 0.0581 |
Brugia malayi | Furin-like cysteine rich region family protein | 0.0301 | 0.3095 | 1 |
Echinococcus granulosus | epidermal growth factor receptor | 0.0162 | 0.1021 | 0.098 |
Trypanosoma cruzi | mitogen-activated protein kinase 3, putative | 0.0132 | 0.0581 | 0.5 |
Trypanosoma brucei | mitogen-activated protein kinase 3, putative | 0.0132 | 0.0581 | 0.5 |
Echinococcus multilocularis | epidermal growth factor receptor | 0.0301 | 0.3095 | 0.3095 |
Echinococcus granulosus | mitogen activated protein kinase 11 | 0.0132 | 0.0581 | 0.0538 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Ki (binding) | = 0.28 uM | Inhibition of human recombinant thymidine phosphorylase expressed in V79 cells | ChEMBL. | 17963370 |
Ki (binding) | = 0.28 uM | Inhibition of human recombinant thymidine phosphorylase expressed in V79 cells | ChEMBL. | 17963370 |
Ki (binding) | = 0.54 uM | Inhibition of human placental thymidine phosphorylase | ChEMBL. | 17963370 |
Ki (binding) | = 0.54 uM | Inhibition of human placental thymidine phosphorylase | ChEMBL. | 17963370 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.